Get the Stockscreener App
377.58
0.32%
1.21
After Hours:
379.00
1.42
+0.38%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $377.58, with a volume of 972.16K.
It is up +0.32% in the last 24 hours and down -3.06% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$376.37
Open:
$377
24h Volume:
972.16K
Relative Volume:
0.81
Market Cap:
$144.12B
Revenue:
$23.82B
Net Income/Loss:
$2.92B
P/E Ratio:
50.01
EPS:
7.55
Net Cash Flow:
$4.02B
1W Performance:
-0.06%
1M Performance:
-3.06%
6M Performance:
-3.53%
1Y Performance:
+15.83%
1-Day Range:
$376.06
$379.81
1-Week Range:
$373.72
$384.46
52-Week Range:
$322.03
$406.19
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital - Ortho Spine News
Spinal Fusion Devices Market Outlook Report 2025-2029: Revenues to Grow by $2.9 Billion Driven by Rising Spinal Disorders, Technological Advances, and Increasing Device Launches - GlobeNewswire Inc.
Massive Stryker Stock Sale by Director Ronda Stryker! - TipRanks
Stryker Corp To Go Ex-Dividend On September 30th, 2025 With 0.84 USD Dividend Per Share - 富途牛牛
Stryker Corp Director Sells 134,961 Shares Amid Market Volatility - AInvest
Stryker Corp(SYK.US) Director Sells US$75.29 Million in Common Stock - 富途牛牛
Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents - Law360
Berkshire Unit Keeps Win Over Two Stryker Joint-Plate Patents - Bloomberg Law News
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker declares quarterly dividend of $0.84 per share - Investing.com
Stryker raises 2025 sales, earnings guidance again after strong quarter - Crain's Grand Rapids Business
What's Driving the Market Sentiment Around Stryker? - 富途牛牛
Stryker Corporation (NYSE:SYK) Not Flying Under The Radar - 富途牛牛
Truist Financial Keeps Their Hold Rating on Stryker (SYK) - The Globe and Mail
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat - Investing.com Canada
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat By Investing.com - Investing.com South Africa
Fund Update: Mesirow Financial Investment Management, Inc. added 43,487 shares of STRYKER ($SYK) to their portfolio - Quiver Quantitative
Truist Securities raises Stryker stock price target to $415 on solid results By Investing.com - Investing.com South Africa
Truist Securities raises Stryker stock price target to $415 on solid results - Investing.com
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $415 - 富途牛牛
Stryker price target raised to $415 from $410 at Truist - TipRanks
What makes Stryker Corporation stock price move sharplyCapitalize on fast-moving stock opportunities - Jammu Links News
Does Stryker Corporation stock perform well during market downturnsIdentify undervalued stocks poised to rally - Jammu Links News
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $407 to $456 - 富途牛牛
Why We're Not Concerned About Stryker Corporation's (NYSE:SYK) Share Price - 富途牛牛
Stryker Corporation (NYSE:SYK) Q2 2025 Earnings Call Transcript - Insider Monkey
Stryker Corp Reports Strong Q2 2025 Earnings Growth - The Globe and Mail
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Stryker (SYK) Raises Guidance As Sales Reach US$6 Billion In Strong Q2 - Yahoo Finance
Stryker (SYK) Analyst Rating Update: Wells Fargo Raises Price Ta - GuruFocus
Stryker (SYK) Receives Price Target Boost from Baird - GuruFocus
Stryker price target raised to $438 from $421 at UBS - TipRanks
Zimmer Biomet Holdings, Inc. shares fall 1.57% intraday as Stryker reports strong Q2 earnings. - AInvest
Stryker Remains on Pace to Benefit From a String of New Product Launches - Morningstar
Stryker lowers expected tariff impact to $175M - Yahoo Finance
Stryker price target raised to $450 from $436 at Baird - TipRanks
Stryker raises 2025 outlook amid 17.3% medical surgery and neurotechnology unit rise - Yahoo Finance
Needham Raises Price Target for Stryker (SYK) to $448, Maintains Buy Rating | SYK Stock News - GuruFocus
Why Stryker’s Stock is Gaining Momentum - TipRanks
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges - Yahoo Finance
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges By GuruFocus - Investing.com Canada
Stryker: Q2 Earnings Snapshot - Greenwich Time
Earnings call transcript: Stryker Q2 2025 beats EPS and revenue forecasts - Investing.com
Stryker shares tumble despite strong Q2 results and raised guidance By Investing.com - Investing.com South Africa
Stryker shares tumble despite strong Q2 results and raised guidance - Investing.com
Stryker (NYSE:SYK) Surprises With Q2 Sales But Stock Drops - Yahoo Finance
Stryker Lifts Guidance on Improving Tariff Outlook - 富途牛牛
Stryker Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Stryker earnings beat by $0.06, revenue topped estimates - Investing.com
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):